GMVDF (G Medical Innovations Holdings) OCF Margin %: -93.40% (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GMVDF G Medical Innovations Holdings Ltd GMVDF
12 GF Score
Price $0.00
View Full Analysis

What is G Medical Innovations Holdings OCF Margin %?

G Medical Innovations Holdings GMVDF 12 OCF Margin % is -93.40% as of Dec. 2022. GuruFocus rates GMVDF with a GF Score™ of 12/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. G Medical Innovations Holdings's Cash Flow from Operations for the six months ended in Dec. 2022 was $-2.05 Mil. G Medical Innovations Holdings's Revenue for the six months ended in Dec. 2022 was $2.20 Mil. Therefore, G Medical Innovations Holdings's OCF Margin % for the quarter that ended in Dec. 2022 was -93.40%.

As of today, G Medical Innovations Holdings's current OCF Yield % is -400,600.00%.

The historical rank and industry rank for G Medical Innovations Holdings's OCF Margin % or its related term are showing as below:

GMVDF' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -418.08


GMVDF's OCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 5.745 vs GMVDF: -418.08


G Medical Innovations Holdings OCF Margin % Related Terms


G Medical Innovations Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for G Medical Innovations Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G Medical Innovations Holdings OCF Margin % Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
OCF Margin %
Get a 7-Day Free Trial -504.77 -113.95 -94.84 -231.69 -418.08

G Medical Innovations Holdings Semi-Annual Data
Sep16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -74.53 -39.76 -507.42 -738.67 -93.40

GMVDF vs WHSI, ISRG, BDX: OCF Margin % Comparison

For the Medical Devices subindustry, G Medical Innovations Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's OCF Margin % distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's OCF Margin % falls into.


GMVDF
12GF Score
G Medical Innovations Holdings Ltd GMVDF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

G Medical Innovations Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

G Medical Innovations Holdings's OCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-18.479/4.42
=-418.08 %

G Medical Innovations Holdings's OCF Margin for the quarter that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=-2.051/2.196
=-93.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -93.40% mean?
G Medical Innovations Holdings (GMVDF) has a OCF Margin % of -93.40% as of Dec. 2022. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on G Medical Innovations Holdings and its competitors.
Is G Medical Innovations Holdings' OCF Margin % too high?
G Medical Innovations Holdings' current OCF Margin % is -93.40%. Overall, G Medical Innovations Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does G Medical Innovations Holdings' OCF Margin % compare to WHSI and ISRG?
G Medical Innovations Holdings' OCF Margin % of -93.40% can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Margin % is 5.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.75, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on G Medical Innovations Holdings and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. G Medical Innovations Holdings's current OCF Margin % is -93.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G Medical Innovations Holdings stock overvalued right now?
G Medical Innovations Holdings (GMVDF) has a current OCF Margin % of -93.40%. The current OCF Margin % is -93.40%. G Medical Innovations Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For G Medical Innovations Holdings (GMVDF), the current OCF Margin % is -93.40% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

G Medical Innovations Holdings Business Description

Address 5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
12GF Score

Get the complete analysis for GMVDF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price